<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03741998</url>
  </required_header>
  <id_info>
    <org_study_id>RenJiH[2018]011</org_study_id>
    <nct_id>NCT03741998</nct_id>
  </id_info>
  <brief_title>Nasopharyngeal Airway Facilitate Transnasal Humidified Rapid Insufflation Ventilatory Exchange</brief_title>
  <official_title>Nasopharyngeal Airway Facilitate Transnasal Humidified Rapid Insufflation Ventilatory Exchange</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For performing transnasal humidified rapid insufflation ventilatory exchange (THRIVE),&#xD;
      jaw-thrust maneuver have to maintain to make sure the airway open and the CO2 clearance&#xD;
      during apnoea. The objective of present study is to prove that nasopharyngeal airway&#xD;
      facilitate THRIVE and no need jaw-thrust maneuver and maintain the similar PO2 and PCO2&#xD;
      during apnoea.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">November 7, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The partial pressure of carbon dioxide (pCO2)</measure>
    <time_frame>From start to end of THRIVE(20 minutes)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The partial pressure of oxygen(PO2)</measure>
    <time_frame>From start to end of THRIVE(20 minutes)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hypoxia</condition>
  <condition>Hypercapnia</condition>
  <arm_group>
    <arm_group_label>THRIVE</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) during induction using jaw-thrust maneuver.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>THRIVE with nasopharyngeal airway</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) during induction with nasopharyngeal airway.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasopharyngeal airway</intervention_name>
    <description>THRIVE with a regular nasopharyngeal airway.</description>
    <arm_group_label>THRIVE with nasopharyngeal airway</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed informed consent.&#xD;
&#xD;
          -  Undergoing surgery with general anaesthesia.&#xD;
&#xD;
          -  Adult, &gt;18 years old.&#xD;
&#xD;
          -  American Society of Anesthesiology classification I-II.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coagulation disorders or a tendency of nose bleeding&#xD;
&#xD;
          -  An episode/exacerbation of congestive heart failure (CHF) that requires a change in&#xD;
             medication, diet or hospitalization from any cause in the last 6 months&#xD;
&#xD;
          -  Severe aortic stenosis or mitral stenosis;&#xD;
&#xD;
          -  Cardiac surgery involving thoracotomy (e.g., coronary artery bypass graft (CABG),&#xD;
             valve replacement surgery) in the last 6 months;&#xD;
&#xD;
          -  Acute myocardial infarction in the last 6 months;&#xD;
&#xD;
          -  Acute arrhythmia (including both tachycardia and bradycardia) with hemodynamic&#xD;
             instability;&#xD;
&#xD;
          -  Diagnosed COPD or current other acute or chronic lung disease requiring supplemental&#xD;
             chronic or intermittent oxygen therapy);&#xD;
&#xD;
          -  Increased intracranial pressure;&#xD;
&#xD;
          -  ASA &gt;II;&#xD;
&#xD;
          -  Mouth, nose, or throat infection;&#xD;
&#xD;
          -  Fever, defined as core body temperature &gt; 37.5Â°C;&#xD;
&#xD;
          -  Pregnancy, breastfeeding or positive pregnancy test;&#xD;
&#xD;
          -  Emergency procedure.&#xD;
&#xD;
          -  Patient with known or suspected difficult airway&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diansan Su, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diansan Su, Dr.</last_name>
    <phone>+862168383702</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>diansan su, Dr.</last_name>
      <phone>+862168383702</phone>
      <email>diansansu@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>November 12, 2018</study_first_submitted>
  <study_first_submitted_qc>November 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2018</study_first_posted>
  <last_update_submitted>July 18, 2019</last_update_submitted>
  <last_update_submitted_qc>July 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

